Works matching AU Bottlaender, Michel


Results: 124
    1
    2

    Highly efficient synthesis of [<sup>11</sup>C]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET.

    Published in:
    Journal of Labelled Compounds & Radiopharmaceuticals, 2000, v. 43, n. 10, p. 997, doi. 10.1002/1099-1344(200009)43:10&lt;997::AID-JLCR385&gt;3.0.CO;2-#
    By:
    • Dolle, Frédéric;
    • Bottlaender, Michel;
    • Demphel, Stéphane;
    • Emond, Patrick;
    • Fuseau, Chantal;
    • Coulon, Christine;
    • Ottaviani, Michele;
    • Valette, Héric;
    • Loc'h, Christian;
    • Halldin, Christer;
    • Mauclaire, Laurent;
    • Guilloteau, Denis;
    • Maziere, Bernard;
    • Crouzel, Christian
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    12

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    13
    14

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    15

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Matteo Tonietto;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    16

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    17

    ndividual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    18

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    19

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    20

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    21

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 2, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    22

    Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 1, p. 1, doi. 10.2967/jnumed.119.231340
    By:
    • Bodini, Benedetta;
    • Poirion, Emilie;
    • Tonietto, Matteo;
    • Benoit, Charline;
    • Palladino, Raffaele;
    • Maillart, Elisabeth;
    • Portera, Erika;
    • Battaglini, Marco;
    • Bera, Geraldine;
    • Kuhnast, Bertrand;
    • Louapre, Céline;
    • Bottlaender, Michel;
    • Stankoff, Bruno
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

    Published in:
    JAMA Neurology, 2022, v. 79, n. 3, p. 228, doi. 10.1001/jamaneurol.2021.5216
    By:
    • Jansen, Willemijn J.;
    • Janssen, Olin;
    • Tijms, Betty M.;
    • Vos, Stephanie J. B.;
    • Ossenkoppele, Rik;
    • Visser, Pieter Jelle;
    • Aarsland, Dag;
    • Alcolea, Daniel;
    • Altomare, Daniele;
    • von Arnim, Christine;
    • Baiardi, Simone;
    • Baldeiras, Ines;
    • Barthel, Henryk;
    • Bateman, Randall J.;
    • Van Berckel, Bart;
    • Binette, Alexa Pichet;
    • Blennow, Kaj;
    • Boada, Merce;
    • Boecker, Henning;
    • Bottlaender, Michel
    Publication type:
    Article
    34
    35

    Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer's disease patients are associated with cognitive impairment.

    Published in:
    Translational Psychiatry, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41398-023-02355-z
    By:
    • Xicota, Laura;
    • Lagarde, Julien;
    • Eysert, Fanny;
    • Grenier-Boley, Benjamin;
    • Rivals, Isabelle;
    • Botté, Alexandra;
    • Forlani, Sylvie;
    • Landron, Sophie;
    • Gautier, Clément;
    • Gabriel, Cecilia;
    • Bottlaender, Michel;
    • Lambert, Jean-Charles;
    • Chami, Mounia;
    • Sarazin, Marie;
    • Potier, Marie-Claude
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Brain PET imaging using 11 C-flumazenil and 11 C-buprenorphine does not support the hypothesis of a mutual interaction between buprenorphine and benzodiazepines at the neuroreceptor level.

    Published in:
    Journal of Cerebral Blood Flow & Metabolism, 2024, v. 44, n. 3, p. 449, doi. 10.1177/0271678X231221040
    By:
    • Auvity, Sylvain;
    • Vodovar, Dominique;
    • Goutal, Sébastien;
    • Cisternino, Salvatore;
    • Chevillard, Lucie;
    • Soyer, Amélie;
    • Bottlaender, Michel;
    • Caillé, Fabien;
    • Mégarbane, Bruno;
    • Tournier, Nicolas
    Publication type:
    Article
    45
    46
    47
    48
    49
    50